Cargando…
Designer nucleases to treat malignant cancers driven by viral oncogenes
Viral oncogenic transformation of healthy cells into a malignant state is a well-established phenomenon but took decades from the discovery of tumor-associated viruses to their accepted and established roles in oncogenesis. Viruses cause ~ 15% of know cancers and represents a significant global heal...
Autores principales: | Scott, Tristan A., Morris, Kevin V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805041/ https://www.ncbi.nlm.nih.gov/pubmed/33441159 http://dx.doi.org/10.1186/s12985-021-01488-1 |
Ejemplares similares
-
Genome editing of oncogenes with ZFNs and TALENs: caveats in nuclease design
por: Shankar, Sumitra, et al.
Publicado: (2018) -
Viral Nucleases
por: Wang, Zhengqiang, et al.
Publicado: (2023) -
Nuclease-like metalloscissors: Biomimetic candidates for cancer and bacterial and viral infections therapy
por: Anjomshoa, Marzieh, et al.
Publicado: (2022) -
Oncogene-Driven Metabolic Alterations in Cancer
por: Min, Hye-Young, et al.
Publicado: (2018) -
The Therapeutic Potential of CRISPR/Cas9 Systems in Oncogene-Addicted Cancer Types: Virally Driven Cancers as a Model System
por: Jubair, Luqman, et al.
Publicado: (2017)